Author Details

Korotaeva, T. V., Research Institute of Rheumatogy named after V. A. Nasonova, Moscow, Russian Federation

Issue Section Title File
Vol 93, No 5 (2017) ORIGINAL STUDIES Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies